Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
1423studies shown
Showing 1,201-1,212 of 1,423
Device study icon
WithdrawnNCT00447096

rTMS for Treatment of Depressed Phase of Bipolarity type II

This study has public registry information. It focuses on bipolarity and currently lists study information in the United States.

In Dallas
Bipolarity, DepressionOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Texas Southwestern Medical Center
Condition
Bipolarity, Depression
Device study icon
CompletedNCT00436020

rTMS in the Treatment of Depression in bipolarity

This study is completed. It focuses on bipolarity and currently lists study information in Australia.

In Prahran
Bipolarity, DepressionOtherFrom 18 Years to 70 Years
Countries
Australia
Sponsor
Bayside Health
Condition
Bipolarity, Depression
Drug study icon
WithdrawnNCT00359125

RU-486 in the Treatment of Depression in bipolarity

This study has public registry information. It focuses on bipolarity and currently lists study information in Canada.

In Vancouver
Bipolarity, DepressionDrugA study involving a medication or substance.From 19 Years to 65 Years
Countries
Canada
Sponsor
University of British Columbia
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT01058668

Safety and Efficacy of Cariprazine for Bipolarity type I

This study is completed. It focuses on bipolarity and currently lists study information in Croatia, Romania, Russian Federation, Serbia, Ukraine, and the United States.

Multiple locations, including Little Rock
BipolarityOtherFrom 18 Years to 65 Years
Countries
United States, Croatia, Romania, ...
Sponsor
Forest Laboratories
Condition
Bipolarity
Drug study icon
CompletedNCT01058096

Safety and Efficacy of Cariprazine for Mania

This study is completed. It focuses on bipolarity and currently lists study information in India and the United States.

Multiple locations, including Long Beach
BipolarityOtherFrom 18 Years to 65 Years
Countries
United States, India
Sponsor
Forest Laboratories
Condition
Bipolarity
Other study type icon
TerminatedNCT01677182

Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolarity type I

This study has public registry information. It focuses on bipolarity and currently lists study information in Bulgaria, Czech Republic, Germany, Poland, Romania, Russian Federation, Serbia, Ukraine, the United Kingdom, and the United States.

Multiple locations, including Birmingham
BipolarityOtherFrom 18 Years to 75 Years
Countries
United States, United Kingdom, Bulgaria, ...
Sponsor
Takeda
Condition
Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.